STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Sponsor: Medical University of South Carolina • ClinicalTrials.gov ID: NCT06922617
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The purpose of this study is to investigate whether non-cigarette tobacco products, namely e-cigarettes (nicotine vapes), can help people who smoke and are in treatment for substance use disorder quit smoking by switching completely to e-cigarettes as compared to FDA-approved medications, namely nicotine replacement therapy in the form of patches and lozenges. Participation will last 6 months and includes 14 weekly study visits and 2 follow-up study visits (in-person, but virtual study visits are possible). Participants will also complete a short daily diary on their phones each day for the first twelve weeks. To qualify, participants (ages 21+) must be enrolled in an outpatient substance use disorder (SUD) treatment program. The study is being done in four regions across South Carolina: Charleston, Pickens/Easley, Conway, and Greenville.
Interventions
-
Switching to E-Cigarette
(Behavioral)
Participants will receive twelve weeks of e-cigarette products with instructions to switch completely at switch date
-
Quitting using Medication
(Drug)
Participants will receive twelve weeks of FDA approved medication, combination NRT, with instructions to quit smoking cigarettes at quit date
-
Counseling
(Behavioral)
Participants will recieve brief weekly counseling to support their quit or switch attempt from cigarettes.
Eligibility criteria
Conditions
Locations
- MUSC Charleston — Charleston, South Carolina, United States
- Shoreline Behavioral Health Services — Conway, South Carolina, United States
- Phoenix Center — Greenville, South Carolina, United States
- Behavioral Health Services of Pickens County — Pickens, South Carolina, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record